SEQUENCE TO VALUE

Our Services

Under the framework of the Enzyme Technology Alliance the independent partners jointly tackle complex development projects spanning from in-silico catalyst discovery over AI-supported enzyme engineering to biocatalyst immobilization, DOE-based process intensification and scale-up of both enzyme production and the chemo-enzymatic process. Like interlocking pieces of a puzzle, the strengths of each member are combined not only to create a new point of contact for the biotech industry, but offer competitive solutions for both superior proteins and chemical entities.

aGroup 91 7. Value 6. Scale Up 5. Process Intensification 4. Process Development 3. Enzyme Engineering 2. Enzyme discovery 1. Sequence
7. Value 6. Scale Up 5. Process Intensification 4. Process Development 3. Enzyme Engineering 2. Enzyme discovery 1. Sequence
7. Value 6. Scale Up 5. Process Intensification 4. Process Development 3. Enzyme Engineering 2. Enzyme discovery 1. Sequence

Your Benefits

The journey from a protein sequence to a final biocatalytic process to deploy at scale requires broad expertise in R&D and manufacturing to enable success.

The Enzyme Technology Alliance now allows start-ups and corporations globally to access the full scope of protein development to marketable (chemical) products.

Founders and members of the alliance are seven technologically complementary European biotech-SMEs, each with a distinct focus in the area of enzyme R&D.

Comprising 50 scientific experts and more than 150 years of combined experience in managing projects ranging from enzyme discovery to facilitating cGMP enzymatic production of API’s.

Our Members

Ultra-high-throughput engineering, Microfluidics

Allozymes applies its patented microfluidics technology to accelerate custom enzyme discovery and development for API production. We combine our ultra-high throughput screening capability (10 Million a day) with proprietary enzyme database, and machine learning models to develop highly selective enzymes for diverse chemistry, API production, with IP FTO. Allozymes supports its clients by delivering accelerated proof–of-concepts, custom enzyme and bioprocess development with in-house capabilities to go from lab to pilot scale, and commercial enzyme production with our global partner network.

aminoverse-logo
Enzyme Engineering, Biocatalyst Panels

Aminoverse enables clients to accelerate and de-risk enzyme innovation in the early value chain from target reaction to tailored enzyme. Founded in 2020, Aminoverse’s CRO services combine enzyme wet lab expertise with in silico design boosted by its recently launched proprietary AI technologies “EnzyMAP” and “EnzyREC”. For biocatalysis, Aminoverse offers the world’s largest collections of unspecific peroxygenases and ketoglutarate-dependent oxygenases for rapid hit screening – free or 3rd party IP and scalable. Aminoverse is the go-to enzyme R&D partner for successful enzyme discovery and next generation enzyme engineering with attractive IP regulations.

bioprodict-logo
AI-driven Engineering platform, Bioinformatics

Bio-Prodict revolutionizes protein engineering with its next-generation, AI-driven 3DM Engineering platform. Our comprehensive in-silico pipeline streamlines protein design at every step—from intelligent protein selection to targeted hotspot mutations and iterative AI-based optimization. Leveraging advanced predictive algorithms and a vast repository of protein family data, 3DM Engineering enables our clients to make confident, data-backed decisions that accelerate research projects and achieve superior results while minimizing the need for labor-intensive trial and error. Integrated IP navigation tools ensure that our clients remain aware of their freedom-to-operate throughout the engineering process, safeguarding commercial viability and avoiding IP conflicts. Bio-Prodict is the trusted partner for next-generation enzyme engineering.

candidum-logo
Discovery, Library Generation

Candidum generates custom enzyme solutions with an emphasis on reducing complexity and improving predictability by integrating computational design into the enzyme development process. We identify the most promising enzymes that natural evolution has to offer and engineer the synthetic potential of selected enzyme templates by means of focused libraries that are customizable towards multiple design targets in parallel. Our holistic approach enables us to quickly adapt to changes in project, process or IP requirements to de-risk R&D projects.

chiralvision-logo
Enzyme Immobilization, Chiral Synthesis

For over 19 years, ChiralVision has designed, developed and scaled-up hundreds of immobilized enzyme processes for all thinkable markets. Chemistry is reinvented by applying biocatalysis and enzyme immobilization to your process. Finding the right enzyme takes you only half way. Designing the production process around it and applying immobilization to allow for more extreme conditions, recycling, continuous processing, and full enzyme removal takes you all the way.

enzymical-logo
Industrial Biocatalysis, Process Development

Enzymicals stands for tailor-made enzymes, customized chemicals and individual process solutions. The German enterprise has created a customer-oriented industrial platform for process development and piloting of chemo-biocatalytic synthetic routes for high-quality fine chemicals. Enzymicals is your experienced partner for industrial biocatalysis from gram to ton-scale with more than a decade of experience. Together with our network partners, our services can be expanded to cGMP production and bulk scale supply.

spinchem-logo
Rotating Bed Reactor, Process Improvement

SpinChem® offers patented technology to businesses in synthesis, production, and purification, including research labs and production facilities. Specializing in solid phase utilization, we aid in both harnessing valuable substances and eliminating hazardous ones from liquids. Our flagship product, the SpinChem® rotating bed reactor, is versatile for applications ranging from water purification and toxic waste treatment to producing renewable fuels, cosmetics, and pharmaceuticals.

How we operate

icon1

In order to ensure the flexibility and independence of all partners, the relationship between the companies is not exclusive.

icon2

This approach has already been proven between the SMEs and offers clear competitive advantages.

icon3

This approach offers room for fulfilling requirements or individual preferences of the clients.

icon4

It allows aligning solutions with client requirements while keeping administrative burden at a minimum.

icon5

A lead partner is available as main contact to the client, and the other partners will be regarded as subcontractors in collaborative projects.

icon6

The client retains full control over the flow of confidential information and benefits from a transparent IP transfer.

Contact us

The ETA Members Allozymes, Aminoverse, Bio-prodict, ChiralVision, Enzymicals, Candidum and SpinChem look forward to meeting you!